Theradaptive
Theradaptive is dedicated to developing innovative therapeutics through advanced protein engineering, aiming to improve the delivery and efficacy of treatments for patients suffering from debilitating conditions related to tissue damage. Their mission is to create safer and more effective therapeutics that address unmet medical needs, particularly in the fields of vascular, soft tissue, and orthopedic repair.
Theradaptive
7495 New Horizon Way Suite 240, Frederick, Maryland, United States
What We Do
An investigational spinal fusion implant designed to promote bone growth and avoid complications associated with traditional bone grafts. It contains the engineered protein AMP2, which enhances safety and efficacy in spinal fusion procedures.
Digital Health Technologies
Application Area
Show More (1)Services
Key People
News & Updates
A publication detailing the results of a preclinical study on the OsteoAdapt SP spinal fusion implant.
Recognition of Theradaptive's innovative technology in the field of spinal treatments.
Announcement of the first patient treated in the OASIS clinical trial, evaluating the safety and efficacy of OsteoAdapt SP.
Awarded by the Maryland Tech Council in recognition of Theradaptive's innovative contributions to the life sciences sector.